News

Exciting Franchise Developments for UAB Orkela and Marriott

Exciting Franchise Developments for UAB Orkela and Marriott

UAB Orkela Expands Franchise Horizons with Marriott

UAB Orkela, a notable player in the hospitality industry, has exciting news to share. With its legal entity code 304099538 and a registered address in Vilnius, Lithuania, Orkela has been making waves in the business world, particularly with its securities recognized on the Bond List of Nasdaq and a public offering under an approved base prospectus.

New Franchise Agreement with ACHM Global Hospitality

The company is thrilled to announce the recent authorization it received under a franchise agreement with ACHM Global Hospitality Licensing S.à r.l.. This partnership opens a new chapter for UAB Orkela as they venture into the operations of an AC Hotel by Marriott.

Location and Business Operations

The newly authorized hotel will be strategically located at Vasario 16-osios Street 1 in Vilnius, Lithuania. This prime location signifies UAB Orkela's commitment to expanding its hotel offerings in desirable urban areas. The choice of site aligns perfectly with the brand's vision of providing excellent service and comfortable accommodations to travelers and locals alike.

The Impact on Hospitality Sector

The opening of the AC Hotel by Marriott is expected to create a significant impact on the local hospitality sector by enhancing the visitor experience. This hotel aims to cater to business and leisure travelers, offering modern amenities and superior service.

Future Expansion Plans

As UAB Orkela embarks on this exciting venture with Marriott, there are whispers of further expansion plans. The company seems poised to enhance its portfolio within the hospitality sector.

Leadership Insights

Leading this initiative is Anastasija Pocien?, the General Manager of UAB Orkela. Anastasija brings a wealth of experience and passion to the operation, ensuring that both guest satisfaction and business objectives are prioritized.

Frequently Asked Questions

What is the recent franchise agreement about?

The recent franchise agreement is between UAB Orkela and ACHM Global Hospitality, allowing UAB Orkela to open an AC Hotel by Marriott.

Where will the new AC Hotel be located?

It will be located at Vasario 16-osios Street 1, Vilnius, Lithuania.

Who is the General Manager of UAB Orkela?

Anastasija Pocien? is the General Manager, leading the new hotel initiative.

How does this impact UAB Orkela's business?

This expansion is a strategic move to enhance their hotel offerings and align with market demands in the hospitality sector, promising growth and increased visibility for the brand.

What amenities will the AC Hotel offer?

The AC Hotel by Marriott aims to provide modern amenities suitable for both business and leisure travelers, focusing on comfort and quality service.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

M&A Source's 2026 Conference Tackles Deal-Making Drama

Updated Category News Views 130

High Stakes and Deep Insights Await in Houston Cracking the nut of lower-middle market transactions ain’t a walk in the park. M&A Source®'s Fall 2026 Conference is gearing up to address the very dramas that lurk behind the scenes. Kicking off November 2-4 at the opulent JW Marriott in Houston, Texas, the event is looking to assemble a heavyweight lineup of...

Continue Reading
Endava Faces Class Action: Investors Eye Their Next Move

Updated Category News Views 0

A Mess That Investors Can't Ignore If you're holding onto Endava plc shares, you've probably felt that gut-punch lately. Yeah, things are getting heated with a class action lawsuit alleging the company played fast and loose with its accounting practices. The complaint's about some shady dealings that may have thrown off investors' perceptions. The Core Allegations This...

Continue Reading
Astellas and Audax Forge $1.34B Immuno-Oncology Deal

Updated Category News Views 36

Big Moves in Immuno-Oncology: Astellas' Latest Bet You hear 'immuno-oncology,' you think breakthrough, right? Well, friends, that's what Astellas and Audax Biosciences are shooting for with their fresh handshake over DAX-044. On October 27, 2026, in Tokyo and Melbourne, the two outfits announced they're joining forces to bring this novel immunotherapy to the table. It's...

Continue Reading
OneQode & AdaniConneX Forge AI Path in India

Updated Category News Views 17

A Major Step Forward in AI Infrastructure When two heavyweights clash, you better believe folks are paying attention. OneQode’s deal with AdaniConneX is like a shot across the bow in the AI infrastructure arena. They’re not just dipping a toe in India’s tech waters; they’re diving headfirst with 14 MW of data center muscle right there in Siruseri Sipcot, Chennai....

Continue Reading
Lynk Pharmaceuticals' Zemprocitinib Shines in Phase III RA Trial

Updated Category News Views 48

A Deep Dive into Lynk Pharmaceuticals' Latest Revelation Lynk Pharmaceuticals just dropped a bombshell with their latest Phase III trial results for zemprocitinib. This selective JAK1 inhibitor seems to be bringing some serious game in the fight against moderate-to-severe rheumatoid arthritis (RA), especially for folks who haven't had much luck with biologics. The drug...

Continue Reading
Brightstar's Cash Pop Shakes Up Illinois Lottery Scene

Updated Category News Views 63

A New Twist in Illinois: Cash Pop's Arrival Here's something fresh off the press: the Illinois Lottery is now on the ride with Brightstar's Cash Pop. This patented game isn't just another number pick—it's an engaging draw-based game featuring hourly draws with price tags of $1, $2, $5, and $10. It's like clockwork, and trust me, it's more than just the usual spin....

Continue Reading
Etisalat Surges: Net Profit Soars 46% Amid Growth

Updated Category News Views 91

Etisalat's Stellar Performance: A Deeper Dive When a company like Etisalat drops news of a whopping 46% increase in net profit year-over-year, you sit up and pay attention. Those numbers aren’t just a flash in the pan; they're the result of some serious strategic maneuvers and ripe market conditions. Etisalat isn't resting on its laurels, and their latest financials...

Continue Reading
Amgen Declares Q4 Dividend Amidst Broad Horizons

Updated Category News Views 16

Amgen's Steady Dividend: A Testament to Stability Diving into the mess that is today's biotech market, Amgen (NASDAQ:AMGN) stands out like a beacon of stability with its recent dividend announcement. The Board's decision to dole out a $2.52 per share dividend for the fourth quarter of 2026 showcases confidence amidst both promising ventures and looming uncertainties....

Continue Reading
2026 World Laureates Forum Drives Science Forward

Updated Category News Views 78

A Meeting of Great Minds in Shanghai Alright, listen up. Shanghai's gearing up to be the nerve center for the 2026 World Laureates Forum (WLF), and it's seething with potential. This ain't your regular science fair; it's a lion's den of brainpower set to crack open the future of science and tech. With the heavy-hitters like Nobel and Turing laureates on the docket, you're...

Continue Reading
Mercado González Opens, Integrates Mexican Culture

Updated Category News Views 27

Dive into Mercado González's Cultural Opening Over in La Habra, Northgate González Market has just flung open the doors to its latest masterpiece: Mercado González. Picture this, a place where the mundanity of grocery shopping melds with a vibrant fiesta of Mexican cuisine, artisanry, and cultural vibes. They transformed an older store into something that commands not...

Continue Reading

Top 5 Most Recently Viewed Articles

Vantage West Credit Union Introduces Buy Now, Pay Later Feature

Updated Category News Views 328

Vantage West Credit Union Launches Innovative BNPL Program Vantage West Credit Union is enhancing the financial landscape for its members with the introduction of its Buy Now, Pay Later (BNPL) program. This new offering allows members to split their eligible debit card purchases into manageable payments over time, making financial flexibility more accessible to everyone....

Continue Reading
Opportunity for Investors to Join DXC Technology Securities Case

Updated Category News Views 77

DXC Technology got hit with a class action lawsuit back in 2024, and let me tell ya, traders were all over the terminals trying to figure out what this meant for their portfolios. The Schall Law Firm took up the case, reminding folks who bought DXC shares between late May 2021 and mid-May 2024 to step forward if they thought they'd lost cash on this ride. Allegations...

Continue Reading
Eldorado Gold Celebrates Recognition as Top TSX Performer

Updated Category News Views 169

Eldorado Gold's Remarkable Recognition in 2025 TSX30 Eldorado Gold Corporation (TSX:ELD) (NYSE:EGO), a distinguished name in gold and base metals production, has recently been acknowledged by the Toronto Stock Exchange as one of the top performers in the TSX30 for the year 2025. This annual ranking highlights the 30 leading companies on the Toronto Stock Exchange over a...

Continue Reading
Blue Hat Interactive Faces Setbacks But Eyes Strategic Recovery

Updated Category News Views 435

Blue Hat Interactive's Stock Update Recently, Blue Hat Interactive Entertainment Technology's stock (BHAT) has fallen to a troubling 52-week low of $0.06. This decline has pushed the company's market capitalization down to approximately $3.35 million. Over the past year, Blue Hat has faced a significant revenue drop of around 23.5%, earning a weak financial health rating....

Continue Reading
InsCorp Reports Strong Earnings and Expands Market Reach

Updated Category News Views 134

Impressive EPS Growth for InsCorp, Inc. InsCorp, Inc. (OTCQX: IBTN) has reported an impressive year-over-year growth in earnings per share (EPS) of 23%. The company’s third quarter results indicate a significant EPS increase to $0.79, up from $0.73 in the previous quarter and $0.64 a year prior. This positive trend illustrates InsCorp's ability to navigate a competitive...

Continue Reading